AIM ImmunoTech, Inc. (AIM)
0.5908
0.00 (0.00%)
USD |
NYAM |
Apr 06, 16:00
0.58
-0.01
(-1.83%)
After-Hours: 20:00
AIM ImmunoTech EPS Diluted (Quarterly) : -1.359 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.301 |
| Curis, Inc. | 1.229 |
| Plus Therapeutics, Inc. | -1.03 |
| Windtree Therapeutics, Inc. | -1.085 |
| Halozyme Therapeutics, Inc. | -1.203 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.175M |
| Revenue (Quarterly) | 0.021M |
| Total Expenses (Quarterly) | 4.196M |
| Enterprise Value | 3.860M |
| Gross Profit Margin (Quarterly) | -295.2% |
| Profit Margin (Quarterly) | -19.88K% |
| Earnings Yield | -1.16K% |
| Normalized Earnings Yield | -1089.54 |